Fate Therapeutics, Inc. (FATE)
2.545
+0.10
(+4.30%)
USD |
NASDAQ |
Aug 25, 16:00
2.505
-0.04
(-1.57%)
After-Hours: 18:59
Fate Therapeutics 1 Year Total Returns (Daily) : 112.2% for Aug. 24, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 24, 2026 | 112.2% |
| August 21, 2026 | 109.9% |
| August 20, 2026 | 116.8% |
| August 19, 2026 | 132.5% |
| August 18, 2026 | 113.3% |
| August 17, 2026 | 140.4% |
| August 14, 2026 | 140.2% |
| August 13, 2026 | 123.0% |
| August 12, 2026 | 190.5% |
| August 11, 2026 | 192.8% |
| August 10, 2026 | 199.5% |
| August 07, 2026 | 185.7% |
| August 06, 2026 | 139.4% |
| August 05, 2026 | 140.7% |
| August 04, 2026 | 142.5% |
| August 03, 2026 | 133.6% |
| July 31, 2026 | 122.7% |
| July 30, 2026 | 120.2% |
| July 29, 2026 | 101.7% |
| July 28, 2026 | 78.46% |
| July 27, 2026 | 95.97% |
| July 24, 2026 | 92.80% |
| July 23, 2026 | 96.88% |
| July 22, 2026 | 108.1% |
| July 21, 2026 | 146.1% |
| Date | Value |
|---|---|
| July 20, 2026 | 147.3% |
| July 17, 2026 | 141.7% |
| July 16, 2026 | 141.6% |
| July 15, 2026 | 164.6% |
| July 14, 2026 | 162.3% |
| July 13, 2026 | 162.6% |
| July 10, 2026 | 167.2% |
| July 09, 2026 | 170.4% |
| July 08, 2026 | 168.8% |
| July 07, 2026 | 184.9% |
| July 06, 2026 | 167.0% |
| July 02, 2026 | 160.7% |
| July 01, 2026 | 164.9% |
| June 30, 2026 | 141.1% |
| June 29, 2026 | 132.7% |
| June 26, 2026 | 90.91% |
| June 25, 2026 | 61.21% |
| June 24, 2026 | 76.07% |
| June 23, 2026 | 89.47% |
| June 22, 2026 | 80.67% |
| June 18, 2026 | 72.73% |
| June 17, 2026 | 63.33% |
| June 16, 2026 | 53.23% |
| June 15, 2026 | 57.65% |
| June 12, 2026 | 47.14% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Agenus, Inc. | 69.69% |
| Amgen, Inc. | 55.28% |
| Anika Therapeutics, Inc. | 121.1% |
| BioCryst Pharmaceuticals, Inc. | 13.08% |
| Imunon, Inc. | -75.54% |